, India
113 views
/nonmisvegliate from Pixabay

Half of Indian health insurance policyholders report claim rejections

83% of respondents also believe health insurers lack modern systems.

Over half of Indian respondents who filed claims in the past three years said their claims were rejected or partially approved for invalid reasons, according to a Local Circles 

Nearly two in five respondents reported waiting between 6 to 48 hours for claims to be approved and hospital discharges to be processed, contrary to the regulator's time-bound directives.  

The survey also found that 83% of respondents believe health insurers lack transparent, web-based communication systems for claim processing. 

Many companies still rely on emails and hospital calls, leaving policyholders uninformed about claim status.  

Respondents expressed scepticism about claim delays, with over 2 in 5 believing insurers deliberately prolong processing to pressure policyholders into accepting lower settlements. Half of the respondents reported experiencing this firsthand.  

The survey was conducted across 327 districts with over 100,000 responses. The findings have been submitted to IRDAI, urging stricter enforcement of reforms and mandating transparent digital systems to streamline claims.
 

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.